MYOM1
Basic information
Region (hg38): 18:3066807-3219968
Links
Phenotypes
GenCC
Source:
- hypertrophic cardiomyopathy (Disputed Evidence), mode of inheritance: AD
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MYOM1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 10 | 356 | 370 | |||
missense | 751 | 24 | 17 | 792 | ||
nonsense | 24 | 24 | ||||
start loss | 0 | |||||
frameshift | 37 | 38 | ||||
inframe indel | 19 | 20 | ||||
splice donor/acceptor (+/-2bp) | 13 | 15 | ||||
splice region | 35 | 50 | 6 | 91 | ||
non coding | 124 | 147 | 277 | |||
Total | 0 | 0 | 860 | 508 | 168 |
Variants in MYOM1
This is a list of pathogenic ClinVar variants found in the MYOM1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
18-3067063-A-C | Benign (May 13, 2021) | |||
18-3067252-G-A | not specified | Uncertain significance (Nov 11, 2015) | ||
18-3067264-A-AT | Hypertrophic cardiomyopathy | Uncertain significance (Nov 24, 2021) | ||
18-3067274-C-CT | not specified • Hypertrophic cardiomyopathy | Likely benign (Dec 21, 2023) | ||
18-3067278-C-A | not specified | Uncertain significance (Oct 27, 2022) | ||
18-3067279-C-G | Uncertain significance (Oct 01, 2020) | |||
18-3067279-C-T | not specified | Uncertain significance (Oct 30, 2022) | ||
18-3067279-CA-TG | Hypertrophic cardiomyopathy | Uncertain significance (Jan 30, 2021) | ||
18-3067280-A-G | not specified • Hypertrophic cardiomyopathy | Benign (Feb 01, 2024) | ||
18-3067280-AC-GT | Hypertrophic cardiomyopathy | Uncertain significance (Oct 25, 2022) | ||
18-3067282-C-G | Hypertrophic cardiomyopathy | Uncertain significance (Jul 07, 2023) | ||
18-3067282-C-T | not specified | Uncertain significance (Oct 16, 2023) | ||
18-3067300-C-T | not specified | Uncertain significance (Jun 01, 2023) | ||
18-3067301-G-A | Hypertrophic cardiomyopathy • not specified | Benign/Likely benign (Jan 15, 2024) | ||
18-3067302-G-A | Hypertrophic cardiomyopathy | Uncertain significance (Dec 30, 2023) | ||
18-3067310-C-T | Hypertrophic cardiomyopathy • not specified | Likely benign (May 31, 2023) | ||
18-3067311-G-T | not specified | Uncertain significance (Feb 20, 2023) | ||
18-3067314-T-TAC | Hypertrophic cardiomyopathy | Uncertain significance (Dec 04, 2022) | ||
18-3067318-C-T | Hypertrophic cardiomyopathy • not specified | Uncertain significance (Feb 13, 2024) | ||
18-3067319-C-T | not specified • Hypertrophic cardiomyopathy • MYOM1-related disorder | Likely benign (Jan 25, 2024) | ||
18-3067325-G-A | Hypertrophic cardiomyopathy • not specified | Likely benign (Oct 13, 2023) | ||
18-3067327-T-C | not specified | Uncertain significance (Jun 14, 2023) | ||
18-3067333-C-T | Non-immune hydrops fetalis • Hypertrophic cardiomyopathy | Conflicting classifications of pathogenicity (May 22, 2023) | ||
18-3067334-G-A | Hypertrophic cardiomyopathy | Conflicting classifications of pathogenicity (Nov 08, 2022) | ||
18-3067339-C-T | Hypertrophic cardiomyopathy • not specified | Conflicting classifications of pathogenicity (Jun 08, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MYOM1 | protein_coding | protein_coding | ENST00000356443 | 37 | 153302 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.73e-40 | 0.00449 | 124445 | 0 | 251 | 124696 | 0.00101 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.618 | 920 | 974 | 0.944 | 0.0000579 | 10960 |
Missense in Polyphen | 315 | 363.6 | 0.86634 | 4053 | ||
Synonymous | -0.0177 | 377 | 377 | 1.00 | 0.0000244 | 3220 |
Loss of Function | 1.93 | 73 | 93.1 | 0.784 | 0.00000492 | 1114 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00279 | 0.00255 |
Ashkenazi Jewish | 0.000299 | 0.000298 |
East Asian | 0.00233 | 0.00228 |
Finnish | 0.000140 | 0.000139 |
European (Non-Finnish) | 0.000903 | 0.000885 |
Middle Eastern | 0.00233 | 0.00228 |
South Asian | 0.00129 | 0.00124 |
Other | 0.000836 | 0.000825 |
dbNSFP
Source:
- Function
- FUNCTION: Major component of the vertebrate myofibrillar M band. Binds myosin, titin, and light meromyosin. This binding is dose dependent.;
- Pathway
- Striated Muscle Contraction
(Consensus)
Recessive Scores
- pRec
- 0.112
Intolerance Scores
- loftool
- rvis_EVS
- 0.56
- rvis_percentile_EVS
- 81.68
Haploinsufficiency Scores
- pHI
- 0.119
- hipred
- Y
- hipred_score
- 0.540
- ghis
- 0.484
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.115
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | High | High | High |
Primary Immunodeficiency | High | High | High |
Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Myom1
- Phenotype
Gene ontology
- Biological process
- extraocular skeletal muscle development;muscle contraction;positive regulation of gene expression;protein kinase A signaling;skeletal muscle thin filament assembly;skeletal muscle myosin thick filament assembly;sarcomere organization;cardiac muscle fiber development;positive regulation of protein secretion;cardiac myofibril assembly;cardiac muscle tissue morphogenesis;striated muscle myosin thick filament assembly
- Cellular component
- striated muscle myosin thick filament;striated muscle thin filament;sarcomere;Z disc;M band
- Molecular function
- protein binding;structural constituent of muscle;kinase binding;identical protein binding;protein homodimerization activity;actin filament binding;muscle alpha-actinin binding